Search This Site:
Clinical Commissioning Groups Logo

JPC Bulletin

Bedfordshire and Luton Joint Prescribing Committee

Ref: JPC Bulletin 293
Bulletin Date: 14/01/21
Review Date: Dec 2023

Insulin Lyumjev® :- a new analogue formulation of insulin lispro

JPC Recommendations:

 

Insulin Lyumjev® (Lilly) :-

 

This is a new analogue insulin formulation of insulin lispro. It is formulated to be faster acting.

 

JPC Recommendation (based on the recommendations from the Diabetic Sub group):-

 

  • The JPC supported the use of Insulin Lyumjev® as a treatment option for the same group of patients as Fiasp® with the exception that Insulin Lyumjev® is for adult patients only.

 

Click here to see the Fiasp® criteria

Additional Information:

Scroll to Top